Afghanistan vs Mongolia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Afghanistan
0.3%
in 2024
Mongolia
0.3%
in 2024
Afghanistan rank
67th
Mongolia rank
67th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Afghanistan
- Mongolia
How they compare
Afghanistan currently reports 0.3% against 0.3% in Mongolia, a difference of 0.0%.
Across all 10 years both countries report, Mongolia has been ahead every year.
Afghanistan ranks 67th and Mongolia ranks 67th of 215 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Mongolia |
| 2020s | 0.3% | 0.3% | 0.0% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Afghanistan or Mongolia?
- Afghanistan, at 0.3% against 0.3% in Mongolia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Afghanistan and Mongolia?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Mongolia?
- 10 years are reported by both, from 2015 to 2024.
- How do Afghanistan and Mongolia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Afghanistan ranks 67th and Mongolia ranks 67th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.